These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1462888)

  • 1. The possible role of bradykinin in the antiischemic activity of ACE-inhibitors.
    Martorana PA; Schölkens BA
    Agents Actions Suppl; 1992; 38 ( Pt 3)():98-102. PubMed ID: 1462888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
    Hartman JC
    Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local inhibition of bradykinin degradation in ischemic hearts.
    Linz W; Martorana PA; Schölkens BA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reduction of infarct size and remodeling after ramipril].
    Martorana PA; Linz W; Schölkens BA
    Z Kardiol; 1994; 83 Suppl 4():63-4. PubMed ID: 7856282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental cardiovascular benefits of angiotensin-converting enzyme inhibitors: beyond blood pressure reduction.
    Schölkens BA; Linz W; Martorana PA
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S26-30. PubMed ID: 1725038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [ACE inhibition: mechanisms of "cardioprotection" in acute myocardial ischemia].
    Schölkens BA; Linz W
    Klin Wochenschr; 1991; 69 Suppl 24():1-5. PubMed ID: 1865630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibitors unmask endogenous kinin production by bovine coronary artery endothelium.
    Hecker M; Bara AT; Busse R
    Eur Heart J; 1993 Nov; 14 Suppl I():161-3. PubMed ID: 8293768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors.
    Linz W; Schölkens BA
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S83-90. PubMed ID: 1282635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apstatin, a selective inhibitor of aminopeptidase P, reduces myocardial infarct size by a kinin-dependent pathway.
    Wolfrum S; Richardt G; Dominiak P; Katus HA; Dendorfer A
    Br J Pharmacol; 2001 Sep; 134(2):370-4. PubMed ID: 11564655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of nitric oxide synthase prevents myocardial protection by ramiprilat.
    Hartman JC; Kurc GM; Hullinger TG; Wall TM; Sheehy RM; Shebuski RJ
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1071-6. PubMed ID: 7523655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by the bradykinin antagonist HOE 140.
    Hartman JC; Wall TM; Hullinger TG; Shebuski RJ
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):996-1003. PubMed ID: 7687728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide.
    Ehring T; Baumgart D; Krajcar M; Hümmelgen M; Kompa S; Heusch G
    Circulation; 1994 Sep; 90(3):1368-85. PubMed ID: 8087948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ramiprilat or captopril on myocardial infarct size: assessment in canine models of ischemia alone and ischemia with reperfusion.
    Black SC; Driscoll EM; Lucchesi BR
    Pharmacology; 1998 Jul; 57(1):35-46. PubMed ID: 9670211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats.
    Liu YH; Yang XP; Sharov VG; Sigmon DH; Sabbath HN; Carretero OA
    Hypertension; 1996 Jan; 27(1):7-13. PubMed ID: 8591891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do angiotensin converting enzyme inhibitors limit myocardial infarct size?
    Miki T; Miura T; Shimamoto K; Urabe K; Sakamoto J; Iimura O
    Clin Exp Pharmacol Physiol; 1993 Jun; 20(6):429-34. PubMed ID: 8339466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of angiotensin-converting enzyme reduces rat liver reperfusion injury via bradykinin-2-receptor.
    Freise H; Palmes D; Spiegel HU
    J Surg Res; 2006 Aug; 134(2):231-7. PubMed ID: 16513137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary vasodilation induced by angiotensin-converting enzyme inhibition in vivo: differential contribution of nitric oxide and bradykinin in conductance and resistance arteries.
    Sudhir K; Chou TM; Hutchison SJ; Chatterjee K
    Circulation; 1996 May; 93(9):1734-9. PubMed ID: 8653880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy.
    Busse R; Fleming I; Hecker M
    J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S31-6. PubMed ID: 7508049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective actions of bradykinin in myocardial ischemia and left ventricular hypertrophy.
    Linz W; Wiemer G; Schölkens BA
    Braz J Med Biol Res; 1994 Aug; 27(8):1949-54. PubMed ID: 7749386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE inhibitor potentiation of bradykinin-induced venoconstriction.
    Hecker M; Blaukat A; Bara AT; Müller-Esterl W; Busse R
    Br J Pharmacol; 1997 Aug; 121(7):1475-81. PubMed ID: 9257930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.